• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

解决围产期物质使用问题:科罗拉多围产期护理质量合作组织主导的三管齐下方法。

Addressing Perinatal Substance Use: A Triad Approach Led by the Colorado Perinatal Care Quality Collaborative.

机构信息

Colorado Perinatal Care Quality Collaborative, Denver, Colorado.

Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado.

出版信息

J Midwifery Womens Health. 2024 Jul-Aug;69(4):586-592. doi: 10.1111/jmwh.13615. Epub 2024 Feb 9.

DOI:10.1111/jmwh.13615
PMID:38339840
Abstract

Unintentional overdose is a leading driver of maternal death in Colorado. The high volume of maternal deaths from preventable causes lends questions to failures in our clinical and community-based care for pregnant and postpartum people. The Colorado Maternal Mortality Review Committee identified 3 main contributors including stigma in the community and health care system, fragmentation of the health care system, and the need for more clinician training. The Colorado Perinatal Care Quality Collaborative led a 3-pronged intervention to address these challenges and improve perinatal care. The first intervention, the Colorado Alliance for Innovation on Maternal Health Substance Use Disorder quality improvement initiative, partnered with birthing hospitals statewide to institute universal screening and timely referral for individuals at risk of substance use disorder (SUD) and perinatal mood and anxiety disorders. The second intervention, the Improve Perinatal Access, Coordination, and Treatment for Behavioral Health initiative, established a perinatal support network within communities. This program assists individuals with SUD, perinatal mood and anxiety disorders, or social needs to navigate the perinatal period. The third intervention, the Colorado Maternal Overdose Matters Plus program, has enhanced in-hospital access to pharmacotherapy for pregnant and postpartum individuals with SUD through training and technical support. These collaborative initiatives aim to minimize barriers to care by integrating inpatient screening, treatment referrals, pharmacotherapy access, and community care support to mitigate maternal mortality in Colorado.

摘要

非故意药物过量是科罗拉多州产妇死亡的主要原因。大量可预防的孕产妇死亡引起了人们对我们为孕妇和产后人群提供的临床和社区护理的失败的质疑。科罗拉多州孕产妇死亡率审查委员会确定了 3 个主要因素,包括社区和医疗保健系统中的污名化、医疗保健系统的碎片化以及对更多临床医生培训的需求。科罗拉多州围产期护理质量合作组织采取了三管齐下的干预措施来应对这些挑战并改善围产期护理。第一个干预措施是“科罗拉多州创新联盟母婴健康物质使用障碍质量改进倡议”,该倡议与全州的分娩医院合作,对有物质使用障碍(SUD)和围产期情绪和焦虑障碍风险的个人进行普遍筛查和及时转介。第二个干预措施是“改善围产期获得、协调和治疗行为健康倡议”,在社区内建立了围产期支持网络。该计划帮助有 SUD、围产期情绪和焦虑障碍或社会需求的个人在围产期期间获得帮助。第三个干预措施是“科罗拉多州孕产妇药物过量事项加计划”,通过培训和技术支持,增加了对患有 SUD 的孕妇和产后个体住院药物治疗的机会。这些合作倡议旨在通过整合住院筛查、治疗转介、药物治疗机会和社区护理支持,最大限度地减少护理障碍,从而降低科罗拉多州的孕产妇死亡率。

相似文献

1
Addressing Perinatal Substance Use: A Triad Approach Led by the Colorado Perinatal Care Quality Collaborative.解决围产期物质使用问题:科罗拉多围产期护理质量合作组织主导的三管齐下方法。
J Midwifery Womens Health. 2024 Jul-Aug;69(4):586-592. doi: 10.1111/jmwh.13615. Epub 2024 Feb 9.
2
Canadian Network for Mood and Anxiety Treatments 2024 Clinical Practice Guideline for the Management of Perinatal Mood, Anxiety, and Related Disorders: Guide de pratique 2024 du Canadian Network for Mood and Anxiety Treatments pour le traitement des troubles de l'humeur, des troubles anxieux et des troubles connexes périnatals.加拿大情绪与焦虑治疗网络2024年围产期情绪、焦虑及相关障碍管理临床实践指南:加拿大情绪与焦虑治疗网络2024年围产期情绪、焦虑及相关障碍治疗实践指南
Can J Psychiatry. 2025 Feb 12:7067437241303031. doi: 10.1177/07067437241303031.
3
Psychological therapies for post-traumatic stress disorder and comorbid substance use disorder.创伤后应激障碍及共病物质使用障碍的心理治疗
Cochrane Database Syst Rev. 2016 Apr 4;4(4):CD010204. doi: 10.1002/14651858.CD010204.pub2.
4
Patient navigation for perinatal substance use disorder treatment: A systematic review.围产期物质使用障碍治疗中的患者导航:系统评价。
Drug Alcohol Depend. 2024 Jul 1;260:111324. doi: 10.1016/j.drugalcdep.2024.111324. Epub 2024 May 8.
5
Incentives for increasing prenatal care use by women in order to improve maternal and neonatal outcomes.为改善孕产妇和新生儿结局而激励女性增加产前检查的使用。
Cochrane Database Syst Rev. 2015 Dec 15;2015(12):CD009916. doi: 10.1002/14651858.CD009916.pub2.
6
Community-based intervention packages for reducing maternal and neonatal morbidity and mortality and improving neonatal outcomes.基于社区的干预方案,用于降低孕产妇和新生儿发病率及死亡率,并改善新生儿结局。
Cochrane Database Syst Rev. 2015 Mar 23;2015(3):CD007754. doi: 10.1002/14651858.CD007754.pub3.
7
Addressing Inequalities in Long Covid Healthcare: A Mixed-Methods Study on Building Inclusive Services.解决长期新冠医疗保健中的不平等问题:一项关于建立包容性服务的混合方法研究。
Health Expect. 2025 Aug;28(4):e70336. doi: 10.1111/hex.70336.
8
Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline.孕前糖尿病与妊娠:内分泌学会和欧洲内分泌学会联合临床实践指南
Eur J Endocrinol. 2025 Jun 30;193(1):G1-G48. doi: 10.1093/ejendo/lvaf116.
9
State Policy Variation in Implementation of Federal Drug and Child Abuse Laws and Stigmatization of Pregnant and Postpartum Individuals with Opioid Use Disorder.联邦药物与儿童虐待法律实施中的州政策差异以及对患有阿片类物质使用障碍的孕妇和产后人群的污名化
J Womens Health (Larchmt). 2025 May;34(5):613-621. doi: 10.1089/jwh.2024.0638. Epub 2025 Feb 11.
10
Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline.糖尿病合并妊娠:内分泌学会与欧洲内分泌学会联合临床实践指南
J Clin Endocrinol Metab. 2025 Jul 13. doi: 10.1210/clinem/dgaf288.

引用本文的文献

1
Perinatal healthcare experiences of pregnant and parenting people with a history of substance use disorder: a qualitative study.有物质使用障碍史的孕妇及育儿者的围产期医疗保健经历:一项定性研究。
BMC Pregnancy Childbirth. 2025 Mar 28;25(1):369. doi: 10.1186/s12884-025-07473-8.
2
Evaluation of a Program Designed to Support Implementation of Prescribing Medication for Treatment of Opioid Use Disorder in Primary Care Practices.一项旨在支持在初级保健机构实施开具药物治疗阿片类物质使用障碍方案的评估。
Ann Fam Med. 2025 Jan 27;23(1):44-51. doi: 10.1370/afm.3190.